ChemSpider 2D Image | 2BSS7XL60S | C17H21Cl2N3O3

2BSS7XL60S

  • Molecular FormulaC17H21Cl2N3O3
  • Average mass386.273 Da
  • Monoisotopic mass385.096008 Da
  • ChemSpider ID102928

More details:






Validated by Experts, Validated by Users, Non-Validated, Removed by Users

123040-16-4 [RN]
123040-69-7 [RN]
141922-90-9 [RN]
2BSS7XL60S
2H-1,4-Benzoxazine-8-carboxamide, N-1-azabicyclo[2.2.2]oct-3-yl-6-chloro-3,4-dihydro-4-methyl-3-oxo-, hydrochloride (1:1) [ACD/Index Name]
Azasetron (hydrochloride)
Azasetron HCl
Azasetron hydrochloride
N-(1-Azabicyclo[2.2.2]oct-3-yl)-6-chlor-4-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-8-carboxamidhydrochlorid (1:1) [German] [ACD/IUPAC Name]
N-(1-Azabicyclo[2.2.2]oct-3-yl)-6-chloro-4-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-8-carboxamide hydrochloride (1:1) [ACD/IUPAC Name]
More...

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

Y 25130 [DBID]
D01613 [DBID]
Y-25130 [DBID]
  • Experimental Physico-chemical Properties
  • Miscellaneous
    • Target Organs:

      5-HT Receptor antagonist TargetMol T1528
    • Bio Activity:

      5-HT Receptor MedChem Express HY-B0068
      5-HT Receptor TargetMol T1528
      5-HT3 Receptors Tocris Bioscience 380
      A selective and potent 5-HT3 antagonist (Ki = 2.9 nM). Tocris Bioscience 0380, 380
      Azasetron HCl is a selective 5-HT3 receptor antagonist with IC50 of 0.33 nM used in the management of nausea and vomiting induced by cancer chemotherapy. MedChem Express http://www.medchemexpress.com/granisetron-hydrochloride.html, HY-B0068
      Azasetron HCl is a selective 5-HT3 receptor antagonist with IC50 of 0.33 nM used in the management of nausea and vomiting induced by cancer chemotherapy. ;Target: 5-HT3 ReceptorAzasetron Hydrochloride is a 5-HT3 receptor antagonist which is used as an anti-emetic.Azasetron inhibited the specific binding of [3H]quipazine to 5-HT3 receptors at the synaptic membranes of the rat cerebral cortex with a Ki value of 2.9 nM. Azasetron showed low affinity for histamine H1 receptors (IC50 = 4.4 microM) but it could not reveal any affinities for the other receptors (5-HT1A, 5-HT2, dopamine D1, dopamine D2, alpha 1-adrenoceptor, alpha 2-adrenoceptor, muscarine and benzodiazepine) even at a 10 microM concentration [1]. Azasetron (0.1-1.0 mg/kg) dose-dependently prolonged the latency to the first vomiting and decreased the number of vomitings induced by cisplatin in dogs. Azasetron is an orally active antiemetic compound against cisplatin and doxorubicin/cyclophosphamide-induced emeses; an MedChem Express HY-B0068
      GPCR/G protein MedChem Express HY-B0068
      GPCR/G protein; Neuronal Signaling; MedChem Express HY-B0068
      Ion Channels Tocris Bioscience 380
      Ligand-gated Ion Channels Tocris Bioscience 380
      Neuroscience TargetMol T1528
      Potent, selective 5-HT3 antagonist Tocris Bioscience 0380, 380

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module, version: 14.00

No predicted properties have been calculated for this compound.

Click to predict properties on the Chemicalize site






Advertisement